Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China
· Delayed Price · Currency is CNY 61.67
+2.79 (4.74%)
At close: Apr 29, 2026
SHA:688193 Market Cap
SHA:688193 has a market cap or net worth of 2.39 billion as of April 29, 2026. Its market cap has increased by 64.31% in one year.
Market Cap
2.39B
Enterprise Value
1.61B
Revenue
161.94M
Ranking
n/a
PE Ratio
237.19
Stock Price
61.67
Market Cap Chart
Since March 30, 2022, SHA:688193's market cap has decreased from 2.59B to 2.39B, a decrease of -7.68%. That is a compound annual growth rate of -1.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.39B | 27.50% |
| Dec 31, 2025 | 1.88B | 35.54% |
| Dec 31, 2024 | 1.38B | -23.32% |
| Dec 29, 2023 | 1.80B | -3.42% |
| Dec 30, 2022 | 1.87B | -27.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemclin Diagnostics | 2.85B |
| Berry Genomics Co.,Ltd | 3.42B |
| Medicalsystem Biotechnology | 3.73B |
| Shanghai Labway Clinical Laboratory | 3.77B |
| Guangdong Hybribio Biotech | 3.80B |
| SMO ClinPlus CO.,LTD. | 4.45B |
| Thalys Medical Technology Group | 4.53B |
| Cowealth Medical China | 6.06B |